Why David Einhorn’s Greenlight prefers this tiny biotech over AI
‘excitement’
-
Greenlight Capital’s third-quarter investor letter had almost nothing good
to say about the hot AI trend, but it does have faith in a tiny biotech.
24 minutes ago
Posts
Seed Newsvine
.jpg)
Joel Fuhrman MD: Nearly Everyone Gets Cancer: http://youtu.be/sGrmA8iylds via @youtube
ReplyDelete